The vast majority of drugs that drug companies seriously pursue are good, and the delay imposed by the approval process means that the cost, in lives of people who could have benefited earlier and some who died, is overwhelming compared to the benefit of screening out inefficacious or unsafe drugs, so Peltzman concludes that this kind of regulation kills more people than it saves.
causalpending
Speaker
Sam PeltzmanEvidence Quote
“my binding was you know to cut to the chase this kind of regulation kills more people than it saves”
Created: 11/11/2026, 5:13:30 AM
Your notes
Loading notes...